Preoperative serum HE4 combined with CA125 testing for predicting the risk of suboptimal cytoreduction in advanced epithelial ovarian cancer. [PDF]
Zhou C, Wu Y, Wang J, Zheng F.
europepmc +1 more source
A HE4 tumormarker bevezetése elektrokemilumineszcens immunkémiai analizátoron
A petefészekrák a nőgyógyászati tumorok között a 2. leggyakoribb daganattípus. Epidemiológia jelentősége mellett kiemelendő, hogy a fejlődő terápiás és diagnosztikus módszerek ellenére 50%-os a daganat mortalitása.
Kovács, Barbara
core
Low-Level Human Epididymis Protein 4 in Seminal Plasma Is an Independent Risk Factor for Poor Semen Liquefaction: A Case Control Study. [PDF]
Wang F +5 more
europepmc +1 more source
Diagnostic performance of ultrasonography-based risk models in differentiating between benign and malignant ovarian tumors in a Chinese cohort. [PDF]
Li W +6 more
europepmc +1 more source
Application of Serum CA125, HE4, ROMA, and CPH-I in the Preoperative Differentiation of Ovarian Tumors: A Diagnostic Accuracy Study. [PDF]
Feng W +6 more
europepmc +1 more source
Retraction Note: Human epididymis protein 4 in association with Annexin II promotes invasion and metastasis of ovarian cancer cells. [PDF]
Zhuang H +7 more
europepmc +1 more source
Comparing and combining O-RADS ultrasound, serum CA125, and HE4 for the preoperative diagnosis of ovarian tumors. [PDF]
Gong J, Li K, Liu Y, Ren M.
europepmc +1 more source
Expression and clinical significance of WBC, hs-CRP, and ROMA index, and tumor markers in endometriosis. [PDF]
Li J, Wang K.
europepmc +1 more source
Development and validation of a serum peptidomic signature for early detection of asymptomatic ovarian cancer: A multi-center prospective study. [PDF]
Li Z +15 more
europepmc +1 more source
Correlation between BRCA mutational status and lymph node metastasis in advanced epithelial ovarian cancer: a retrospective study. [PDF]
Guan M +6 more
europepmc +1 more source

